Pharmaceutical News

RSS

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

About 100 drugs already approved by the U.S. Food and Drug Administration (FDA) for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, brucellosis, and Mediterranean spotted fever.

29 Jul 2014

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Veloxis Pharmaceuticals A/S and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.

28 Jul 2014

FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.

28 Jul 2014

Melatonin has protective effects on traumatic brain injury-induced cerebral cortex

Traumatic brain injury can cause post-traumatic neurodegenerations with an increase in reactive oxygen species and reactive oxygen species-mediated lipid peroxidation. Melatonin, a non-enzymatic antioxidant and neuroprotective agent, has been shown to counteract oxidative stress-induced pathophysiologic conditions like cerebral ischemia/reperfusion injury, neuronal excitotoxicity and chronic inflammation.

26 Jul 2014

Fitnessedge.net adds new articles on using hGH peptides for anti-aging, hGH replacement therapy

Fitnessedge.net, a website that is devoted to offering readers the most up-to-date information about various weight loss programs, has just added some new and educational articles on using hGH peptides for anti-aging and hGH replacement therapy.

26 Jul 2014

Research project examines pros and cons of launching multiple products in same therapeutic area

In today's marketplace, launching multiple products for a common therapeutic area is costly and challenging - as is managing a portfolio of products in the same therapeutic area.

26 Jul 2014

Minister Ambrose calls for proposals to tackle prescription drug abuse

The Honourable Rona Ambrose, Minister of Health, today issued a national Call for Proposals to improve the prescribing practices for prescription drugs that have a high risk of abuse or addiction.

26 Jul 2014

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.

26 Jul 2014

ScriptPro to bring TCGRx adherence packaging technologies to pharmacies across US

ScriptPro, of Mission, Kansas, and TCGRx, of Powers Lake, Wisconsin, announce that they will be exclusive partners in a distribution and co-marketing agreement allowing ScriptPro to bring TCGRx adherence packaging technologies to retail pharmacies throughout the United States.

26 Jul 2014

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.

26 Jul 2014

CPhI South America 2014 to be held in São Paulo from 5 to 7 August 2014

Leading events organizer UBM Live announces that CPhI South America is returning for the seventh year to São Paulo, Brazil from 5th to 7th August 2014.

26 Jul 2014

Health Canada offers tips on proper use of topical antiseptics to reduce infections

Health Canada is reminding healthcare professionals, caregivers and consumers of the safe use of topical antiseptics used to clean the skin before an operation (preoperative) or before an injection (preinjection).

26 Jul 2014

EGPAF applauds new licensing agreement to improve access to HIV medication for children

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the new licensing agreement between the Medicines Patent Pool (MPP) and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate (TAF), a promising new HIV medication.

26 Jul 2014

Study investigates ventilation strategies used during anaesthesia given for abdomen surgery

A multi-centre study at 30 centres across Europe, North and South America involving a total of 900 test subjects has investigated various ventilation strategies currently used during anaesthesia given for surgical procedures involving the abdomen to see just how effective they are.

26 Jul 2014

XPro1595 drug can protect vulnerable neurons, reduce motor deficits in Parkinson's model

An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson's disease, researchers at Emory University School of Medicine have shown.

26 Jul 2014

EMA recommends full marketing approval for IMBRUVICA in the European Union

Pharmacyclics, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending the granting of full marketing approval for IMBRUVICA (ibrutinib) in the European Union.

25 Jul 2014

Funding for antibiotic research in the UK are inadequate, study reveals

Less than 1% of research funding awarded by public and charitable bodies to UK researchers in 2008–13 was awarded for research on antibiotics, according to new research published in The Lancet Infectious Diseases.

25 Jul 2014

Biogen Idec receives marketing authorization from EC for multiple sclerosis drug

Today Biogen Idec announced that the European Commission (EC) has granted marketing authorization for PLEGRIDY (peginterferon beta-1a) as a treatment for adults with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).

25 Jul 2014

Genticel provides update on patents granted in the USA and Asia

Genticel, a French biotechnology company and leading developer of therapeutic vaccines, provides an update on patents that have recently enriched its intellectual property estate.

25 Jul 2014

Exposure to light at night renders breast cancer completely resistant to drug

Exposure to light at night, which shuts off nighttime production of the hormone melatonin, renders breast cancer completely resistant to tamoxifen, a widely used breast cancer drug, says a new study by Tulane University School of Medicine cancer researchers.

25 Jul 2014

Pharmaceutical News

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

Melatonin has protective effects on traumatic brain injury-induced cerebral cortex

Fitnessedge.net adds new articles on using hGH peptides for anti-aging, hGH replacement therapy

Research project examines pros and cons of launching multiple products in same therapeutic area

Minister Ambrose calls for proposals to tackle prescription drug abuse

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

ScriptPro to bring TCGRx adherence packaging technologies to pharmacies across US

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

CPhI South America 2014 to be held in São Paulo from 5 to 7 August 2014

Health Canada offers tips on proper use of topical antiseptics to reduce infections

EGPAF applauds new licensing agreement to improve access to HIV medication for children

Study investigates ventilation strategies used during anaesthesia given for abdomen surgery

XPro1595 drug can protect vulnerable neurons, reduce motor deficits in Parkinson's model

EMA recommends full marketing approval for IMBRUVICA in the European Union

Funding for antibiotic research in the UK are inadequate, study reveals

Biogen Idec receives marketing authorization from EC for multiple sclerosis drug

Genticel provides update on patents granted in the USA and Asia

Exposure to light at night renders breast cancer completely resistant to drug

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News